Distinct Requirements for FGFR1 and FGFR2 in Primitive Endoderm Development and Exit from Pluripotency

被引:129
|
作者
Molotkov, Andrei [1 ]
Mazot, Pierre [1 ]
Brewer, J. Richard [1 ,2 ]
Cinalli, Ryan M. [1 ]
Soriano, Philippe [1 ]
机构
[1] Icahn Sch Med Mt Sinai, Tisch Canc Inst, Dept Cell Dev & Regenerat Biol, New York, NY 10029 USA
[2] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06519 USA
关键词
EMBRYONIC STEM-CELLS; EARLY MOUSE EMBRYO; GROWTH-FACTOR; SELF-RENEWAL; PREIMPLANTATION EMBRYO; TARGETED DISRUPTION; SIGNALING PATHWAY; GENE-EXPRESSION; FATE DECISIONS; GROUND-STATE;
D O I
10.1016/j.devcel.2017.05.004
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Activation of the FGF signaling pathway during preimplantation development of the mouse embryo is known to be essential for differentiation of the inner cell mass and the formation of the primitive endoderm (PrE). We now show using fluorescent reporter knockin lines that Fgfr1 is expressed in all cell populations of the blastocyst, while Fgfr2 expression becomes restricted to extraembryonic lineages, including the PrE. We further show that loss of both receptors prevents the development of the PrE and demonstrate that FGFR1 plays a more prominent role in this process than FGFR2. Finally, we document an essential role for FGFRs in embryonic stem cell (ESC) differentiation, with FGFR1 again having a greater influence than FGFR2 in ESC exit from the pluripotent state. Collectively, these results identify mechanisms through which FGF signaling regulates inner cell mass lineage restriction and cell commitment during preimplantation development.
引用
收藏
页码:511 / +
页数:20
相关论文
共 50 条
  • [41] Oxidative stress differentially regulates the expression of FGFR1 and FGFR2 in differentiated ARPE-19 cells.
    Alizadeh, M
    Wada, M
    Handa, JT
    Hjelmeland, LM
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2001, 42 (04) : S755 - S755
  • [42] FGF signaling through FGFR1 or FGFR2 is a negative regulator of chondrocytic growth in fetal growth plate.
    Aikawa, T
    Koike, T
    Segre, GV
    Colvin, J
    Ornitz, D
    Lee, K
    JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 : S188 - S188
  • [43] Mesenchymal FGFR1 and FGFR2 control patterning of the ureteric mesenchyme by balancing SHH and BMP4 signaling
    Deuper, Lena
    Meuser, Max
    Thiesler, Hauke
    Jany, Ulrich W. H.
    Rudat, Carsten
    Hildebrandt, Herbert
    Trowe, Mark-Oliver
    Kispert, Andreas
    DEVELOPMENT, 2022, 149 (17):
  • [44] Anti-tumor activity of infigratinib, a potent and selective inhibitor of FGFR1, FGFR2 and FGFR3, in FGFR fusion-positive cholangiocarcinoma and other solid tumors
    Li, Gary
    Krook, Melanie
    Roychowdhury, Sameek
    Avogadri, Francesca
    Ye, Yining
    Moran, Susan
    CANCER RESEARCH, 2019, 79 (13)
  • [45] Aberrations in FGFR1, FGFR2, and RIP5 Expression in Human Congenital Anomalies of the Kidney and Urinary Tract (CAKUT)
    Kelam, Nela
    Racetin, Anita
    Polovic, Mirjana
    Benzon, Benjamin
    Ogorevc, Marin
    Vukojevic, Katarina
    Durdov, Merica Glavina
    Huljev, Ana Dunatov
    Prusac, Ivana Kuzmic
    Caric, Davor
    Raguz, Fila
    Kostic, Sandra
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (24)
  • [46] Sunitinib in Patients With Breast Cancer With FGFR1 or FGFR2 Amplifications or Mutations: Results From the Targeted Agent and Profiling Utilization Registry Study
    Calfa, Carmen J.
    Rothe, Michael
    Mangat, Pam K.
    Garrett-Mayer, Elizabeth
    Ahn, Eugene R.
    Burness, Monika L.
    Gogineni, Keerthi
    Rohatgi, Nitin
    Al Baghdadi, Tareq
    Conlin, Alison
    Gaba, Anu
    Hamid, Omid
    Krishnamurthy, Jairam
    Gavini, Naga Jyothi
    Gold, Philip J.
    Rodon, Jordi
    Rueter, Jens
    Thota, Ramya
    Grantham, Gina N.
    Hinshaw, Dominique C.
    Gregory, Abigail
    Halabi, Susan
    Schilsky, Richard L.
    JCO PRECISION ONCOLOGY, 2024, 8
  • [47] Loss of Fgfr1 and Fgfr2 in Scleraxis-lineage cells leads to enlarged bone eminences and attachment cell death
    Wernle, Kendra K.
    Sonnenfelt, Michael A.
    Leek, Connor C.
    Ganji, Elahe
    Sullivan, Anna Lia
    Offutt, Claudia
    Shuff, Jordan
    Ornitz, David M.
    Killian, Megan L.
    DEVELOPMENTAL DYNAMICS, 2023, 252 (09) : 1180 - 1188
  • [48] ARQ 087 inhibits FGFR signaling and rescues aberrant cell proliferation and differentiation in experimental models of craniosynostoses and chondrodysplasias caused by activating mutations in FGFR1, FGFR2 and FGFR3
    Balek, Lukas
    Gudernova, Iva
    Vesela, Iva
    Hampl, Marek
    Oralova, Veronika
    Kunova Bosakova, Michaela
    Varecha, Miroslav
    Nemec, Pavel
    Hall, Terence
    Abbadessa, Giovanni
    Hatch, Nan
    Buchtova, Marcela
    Krejci, Pavel
    BONE, 2017, 105 : 57 - 66
  • [49] Defective FGFR1 Signaling Disrupts Glucose Regulation: Evidence From Humans With FGFR1 Mutations
    Stamou, Maria, I
    Chiu, Crystal J.
    Jadhav, Shreya, V
    Lopes, Vanessa Ferreira
    Salnikov, Kathryn B.
    Plummer, Lacey
    Lippincott, Margaret F.
    Lee, Hang
    Seminara, Stephanie B.
    Balasubramanian, Ravikumar
    JOURNAL OF THE ENDOCRINE SOCIETY, 2024, 8 (08)
  • [50] A requirement for Fgfr2 in middle ear development
    Rigueur, Diana
    Roberts, Ryan R.
    Bobzin, Lauren
    Merrill, Amy E.
    GENESIS, 2019, 57 (01)